Paragon 28 Inc (FRA:7GQ)
€ 9.35 0 (0%) Market Cap: 792.44 Mil Enterprise Value: 860.09 Mil PE Ratio: 0 PB Ratio: 6.01 GF Score: 34/100

Paragon 28 Inc at Canaccord Genuity Growth Conference Transcript

Aug 09, 2023 / 12:30PM GMT
Release Date Price: €13.6 (-0.73%)
Kyle Rose
Canaccord Genuity - Analyst

Good morning, everybody. I'm Kyle Rose. I'm one of the medical technology analysts here at Canaccord. I want to thank everybody for joining us at our Annual Growth Conference. It's always an honor to get everybody together. So we're glad to have everybody here today.

So this morning, I am joined by one of the more innovative and fun companies to cover within my space, Paragon 28. They are a very differentiated focused player in the foot and ankle space. With me today are Albert DaCosta, the CEO; as well as Steve Deitsch, CFO. Thank you both for joining me.

Before we begin, I need to just point anybody any disclosures if and where applicable, you can find those on our conference website, our firm website. There's a lot of places you can find those. And we're going to do a little bit of a hybrid today. We're going to have a quick presentation just so everybody can get a lay of the land and learn the story, and then we're going to dig into some of the Q&A thereafter.

So without any further ado, I'm going to pass it over to the Paragon

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot